The company said the proposed project is planned as a luxury housing development and is strategically located in one of Mumbai’s most sought-after residential micro-markets.
Godrej Properties in its exchange filing said the encouraging response in its developments at Godrej Trilogy in Worli and Godrej Avenue Eleven in Mahalaxmi further underscores the sustained interest in luxury residences across South and Central Mumbai.
It said Marine Lines is characterized by limited land availability, a rich heritage, an established neighbourhood fabric, and a strategic location along Mumbai’s iconic coastline. It added that its connectivity to the city’s premier business, cultural and lifestyle hubs, particularly via the Coastal Road, the area continues to attract strong demand from end users and affluent buyers.
“Mumbai continues to be a key market for us and our premium and luxury projects in the city have seen a consistently strong response. Our tailor-made developments for South Mumbai have been particularly well received, which gives us confidence in the long-term attractiveness of well-located, high quality homes in this market,” Gaurav Pandey, the MD and CEO of Godrej Properties, said.
On another note, earlier this month, the company informed the NSE that the estimated financial impact of the settlement of disputes with regards to the Godrej Air Project in Gurugram is around ₹70 crore. It said it would update the same in its public disclosure once the actions under the Settlement Agreement are completed.
Godrej Properties had made the disclosure after the exchange had sought clarification from its with regards to a media report which stated that Orris Infrastructure and Godrej Properties had settled the dispute.
The company said the dispute was amicably, finally and conclusively settled via a Settlement Agreement dated August 25, 2026, post discussions between the parties, which spanned over a month. It said the parties were undertaking steps to implement the agreed actions under the settlement.
Shares of Godrej Properties ended the previous session 1.6% higher at ₹1,697.5 apiece. The stock has declined 16.4% in the past month.
Also Read: Fortis Healthcare shares in focus after SC allows forensic audit to go ahead